3rd Quarter - Report

FEDERAL HEALTH POLICY STRATEGIES for KIDNEY CARE PARTNERS

Firm
Client
Income
$80,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

H.R. 2199/S. 1173 Restore Protections for Dialysis Patients Act of 2025; issues related to ESRD program policy, including model changes at Centers for Medicare and Medicaid Innovation on treatment choices and transplantation; H.R. 6214/S. 2730 Kidney Care Access Improvement Act and issues related to promotion of clinical innovation and labor cost increases in the Medicare ESRD program; issues related to community engagement requirements interim final rule.

LobbyistCovered position, as disclosed
COLIN ROSKEY —

Contacted: SENATE; Office of Management & Budget (OMB); Executive Office of the President (EOP); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Bills named: S. 1173 (119th), H.R. 6214 (119th), H.R. 2199 (119th), S. 2730 (119th)

Health Issues HCR

H.R. 2199/S. 1173 Restore Protections for Dialysis Patients Act of 2025; issues related to ESRD program policy, including model changes at Centers for Medicare and Medicaid Innovation on treatment choices and transplantation; H.R. 6214/S. 2730 Kidney Care Access Improvement Act and issues related to promotion of clinical innovation and labor cost increases in the Medicare ESRD program; issues related to community engagement requirements interim final rule.

LobbyistCovered position, as disclosed
COLIN ROSKEY —

Contacted: Office of Management & Budget (OMB); Executive Office of the President (EOP); SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Bills named: S. 2730 (119th), S. 1173 (119th), H.R. 2199 (119th), H.R. 6214 (119th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.